Smith Stan 4
4 · MAIA Biotechnology, Inc. · Filed Mar 5, 2025
Insider Transaction Report
Form 4
Smith Stan
Director
Transactions
- Purchase
Common Stock
2025-03-03$1.50/sh+25,000$37,500→ 1,205,060 total(indirect: See Footnote) - Purchase
Warrants
2025-03-03$1.85/sh+25,000$46,250→ 25,000 total(indirect: See footnote)Exercise: $1.85From: 2026-03-03Exp: 2031-03-03→ Common Stock (25,000 underlying)
Footnotes (4)
- [F1]The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on March 3, 2025.
- [F2]These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
- [F3]These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on March 3, 2025. The options are exercisable beginning on the one-year anniversary of the issuance date and expire 6-years after the initial issuance date.
- [F4]These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.